Press Releases

Press Releases

Date Title and Summary Additional Formats
Toggle Summary Daré Bioscience, Inc. to Present at the Dawson James Small Cap Growth Conference
SAN DIEGO , Oct. 23, 2018 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a clinical-stage, women’s biopharmaceutical company, today announced that John Fair , Chief Business Officer, will present at the Dawson James Securities 4th Annual Small Cap Growth Conference on Tuesday, October
View HTML
Toggle Summary Daré Bioscience, Inc. to Present an Overview of Novel Intra-Vaginal Ring (IVR) Technologies at the Partnership Opportunities in Drug Delivery (PODD) Meeting Held in Boston, MA October 17th – 18th
SAN DIEGO , Oct. 15, 2018 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a clinical-stage, women’s health-focused biopharmaceutical company, today announced it will be presenting scientific and technical details on its innovative intra-vaginal ring (IVR) technologies at the Partnership
View HTML
Toggle Summary Daré Bioscience, Inc. to Present at the 2018 BIO Investor Forum
SAN DIEGO , Oct. 10, 2018 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a clinical-stage, women’s biopharmaceutical company, today announced that Sabrina Martucci Johnson , President and Chief Executive Officer, will present at the 2018 BIO Investor Forum on Wednesday, October 17, 2018
View HTML
Toggle Summary Greg Matz Joins Daré Bioscience Board of Directors
SAN DIEGO , Sept. 17, 2018 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a clinical-stage, women’s biopharmaceutical company, today announced the appointment of Greg Matz to its board of directors. Most recently, Mr. Matz served as the Senior Vice President and Chief Financial Officer
View HTML
Toggle Summary Daré Bioscience, Inc. to Present at the H.C. Wainwright 20th Annual Global Investment Conference
Update on recent discussions with the FDA on the Topical 5% Sildenafil Citrate Cream for Female Sexual Arousal Disorder, and on other protofolio programs SAN DIEGO , Aug. 30, 2018 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a clinical-stage, women’s biopharmaceutical company, today
View HTML
Toggle Summary Daré Bioscience, Inc. to Present at the Canaccord Genuity 38th Annual Growth Conference
SAN DIEGO , Aug. 02, 2018 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a clinical-stage, women’s biopharmaceutical company, today announced that John Fair , Chief Business Officer, will present at the Canaccord Genuity 38th Annual Growth Conference on Thursday, August 9, 2018 at 1:00
View HTML
Toggle Summary Daré Bioscience, Inc. Announces Asset Transfer Agreement with Hydra Biosciences, Inc. for CatSper Contraceptive Target
CatSper antagonist has potential to provide pregnancy prevention via administration to either women or men as a novel, rapidly reversible, non-hormonal contraceptive SAN DIEGO , July 16, 2018 (GLOBE NEWSWIRE) -- Daré Bioscience , Inc.  (NASDAQ:DARE), a clinical-stage, women’s biopharmaceutical
View HTML
Toggle Summary Daré Bioscience, Inc. Expands Leadership Team, Appointing David Friend, Ph.D. to Chief Scientific Officer
SAN DIEGO , June 06, 2018 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc.  (NASDAQ:DARE), a clinical-stage, women’s biopharmaceutical company, today announced the appointment of David Friend , Ph.D., to the newly created role of Chief Scientific Officer (CSO). “We are excited to add Dr.
View HTML
Toggle Summary Daré Bioscience, Inc. Expands Leadership Team, Appointing Mary Jarosz, RPh, to Global Head of Regulatory Affairs
SAN DIEGO , June 04, 2018 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc.  (NASDAQ:DARE), a clinical-stage, women’s biopharmaceutical company, today announced the appointment of Mary Jarosz , RPh, to the newly created role of Global Head of Regulatory Affairs.
View HTML
Toggle Summary EY Announces that Sabrina Martucci Johnson, CEO of Daré Bioscience, Inc., is an Entrepreneur Of The Year® 2018 Award Finalist in San Diego
SAN DIEGO , May 16, 2018 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc.  (NASDAQ:DARE), a clinical-stage, women’s biopharmaceutical company focused on women’s sexual and reproductive health, announced today that President and CEO Sabrina Martucci Johnson is a finalist for the Entrepreneur Of The Year ®
View HTML